Merck & Co., Inc.
MRK
株式のランク
#37
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
株価
$148.36
最終同期: 2026-10-20
時価総額
$366.03B
変化（1日）
3.31%
変化（1年）
69.32%
国
US
取引 Merck & Co., Inc. (MRK)
カテゴリー
Healthcare
Merck & Co., Inc.（MRK）の収益
Jun 2026 時点の収益 TTM: $66.40B
Merck & Co., Inc. の最新の財務報告によると、現在の収益 (TTM) は $66.40B です。2024 年には $64.17B の収益があり、これは 2023 年の $60.12B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Merck & Co., Inc. の収益履歴（2000 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $66.40B | 2.14% |
| 2025 | $65.01B | 1.31% |
| 2024 | $64.17B | 6.74% |
| 2023 | $60.12B | 1.40% |
| 2022 | $59.28B | 21.72% |
| 2021 | $48.70B | 17.31% |
| 2020 | $41.52B | 6.13% |
| 2019 | $39.12B | -7.50% |
| 2018 | $42.29B | 5.41% |
| 2017 | $40.12B | 0.79% |
| 2016 | $39.81B | 0.78% |
| 2015 | $39.50B | -6.48% |
| 2014 | $42.24B | -4.08% |
| 2013 | $44.03B | -6.84% |
| 2012 | $47.27B | -1.62% |
| 2011 | $48.05B | 4.48% |
| 2010 | $45.99B | 67.66% |
| 2009 | $27.43B | 15.00% |
| 2008 | $23.85B | -1.44% |
| 2007 | $24.20B | 6.90% |
| 2006 | $22.64B | 2.84% |
| 2005 | $22.01B | -4.18% |
| 2004 | $22.97B | 2.17% |
| 2003 | $22.49B | 4.85% |
| 2002 | $21.45B | 1.16% |
| 2001 | $21.20B | -47.48% |
| 2000 | $40.36B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $79.67B | 19.98% |
US
|
|
| $99.34B | 49.60% |
US
|
|
| $64.39B | -3.03% |
US
|
|
| $77.52B | 16.74% |
CH
|
|
| $56.26B | -15.27% |
CH
|
